Cargando…

Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1

This is a report of 3 patients diagnosed with idiopathic macular telangiectasia type 1 (MacTel 1) at Medical Retina Center of the University of Eye Clinic of Genova and then prospectically followed for a mean time of 26 months between 2016 and 2019. It is the first report of patients affected by Mac...

Descripción completa

Detalles Bibliográficos
Autores principales: Cirafici, Paola, Musolino, Maria, Saccheggiani, Michela, Traverso, Carlo Enrico, Nicolò, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077428/
https://www.ncbi.nlm.nih.gov/pubmed/33976663
http://dx.doi.org/10.1159/000509850
_version_ 1783684881887264768
author Cirafici, Paola
Musolino, Maria
Saccheggiani, Michela
Traverso, Carlo Enrico
Nicolò, Massimo
author_facet Cirafici, Paola
Musolino, Maria
Saccheggiani, Michela
Traverso, Carlo Enrico
Nicolò, Massimo
author_sort Cirafici, Paola
collection PubMed
description This is a report of 3 patients diagnosed with idiopathic macular telangiectasia type 1 (MacTel 1) at Medical Retina Center of the University of Eye Clinic of Genova and then prospectically followed for a mean time of 26 months between 2016 and 2019. It is the first report of patients affected by MacTel 1 treated with dexamethasone (DEX) implant as a first choice of treatment. Aim of our study is to better characterize the disease using a multimodal wide-field imaging and to determine efficacy of DEX implant on MacTel 1 in terms of central macular thickness (CMT) and best-corrected visual acuity (BCVA). MacTel 1 is a rare unilateral disease, characterized by telangiectatic retinal capillaries, cystoid macular edema, and lipid deposition occurring temporal to the fovea. Patients underwent a comprehensive ophthalmic examination, BCVA, swept-source optical coherence tomography (SS-OCT), SS-OCT angiography (SS-OCTA), ultra-widefield (UWF) color, and fluorescein angiography (FA) fundus photograph. All the patients presented monolateral reduced BCVA and macular edema with increased CMT evaluated by SS-OCT. With SS-OCTA, we showed that the telangiectasia-associated vascular changes originate in the deep retinal vascular plexus and as a consequence macular edema and exudation develop causing vision loss. Furthermore, UWF imaging helped us to highlight vascular changes typical of Coats Disease at the far retinal periphery. All the patients were treated with DEX intravitreal implant, showing a decrease in CMT and a stabilization of visual acuity. Due to the recurrent nature of macular edema, patients underwent a mean of 4 DEX implants during the follow-up period. In order to address the clinical features of this uncommon disease avoiding diagnostic errors, it might be important to use a multimodal imaging approach. The anatomical and functional beneficial effects of DEX implant were well evident although transient.
format Online
Article
Text
id pubmed-8077428
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-80774282021-05-10 Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1 Cirafici, Paola Musolino, Maria Saccheggiani, Michela Traverso, Carlo Enrico Nicolò, Massimo Case Rep Ophthalmol Case Report This is a report of 3 patients diagnosed with idiopathic macular telangiectasia type 1 (MacTel 1) at Medical Retina Center of the University of Eye Clinic of Genova and then prospectically followed for a mean time of 26 months between 2016 and 2019. It is the first report of patients affected by MacTel 1 treated with dexamethasone (DEX) implant as a first choice of treatment. Aim of our study is to better characterize the disease using a multimodal wide-field imaging and to determine efficacy of DEX implant on MacTel 1 in terms of central macular thickness (CMT) and best-corrected visual acuity (BCVA). MacTel 1 is a rare unilateral disease, characterized by telangiectatic retinal capillaries, cystoid macular edema, and lipid deposition occurring temporal to the fovea. Patients underwent a comprehensive ophthalmic examination, BCVA, swept-source optical coherence tomography (SS-OCT), SS-OCT angiography (SS-OCTA), ultra-widefield (UWF) color, and fluorescein angiography (FA) fundus photograph. All the patients presented monolateral reduced BCVA and macular edema with increased CMT evaluated by SS-OCT. With SS-OCTA, we showed that the telangiectasia-associated vascular changes originate in the deep retinal vascular plexus and as a consequence macular edema and exudation develop causing vision loss. Furthermore, UWF imaging helped us to highlight vascular changes typical of Coats Disease at the far retinal periphery. All the patients were treated with DEX intravitreal implant, showing a decrease in CMT and a stabilization of visual acuity. Due to the recurrent nature of macular edema, patients underwent a mean of 4 DEX implants during the follow-up period. In order to address the clinical features of this uncommon disease avoiding diagnostic errors, it might be important to use a multimodal imaging approach. The anatomical and functional beneficial effects of DEX implant were well evident although transient. S. Karger AG 2021-04-06 /pmc/articles/PMC8077428/ /pubmed/33976663 http://dx.doi.org/10.1159/000509850 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Cirafici, Paola
Musolino, Maria
Saccheggiani, Michela
Traverso, Carlo Enrico
Nicolò, Massimo
Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1
title Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1
title_full Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1
title_fullStr Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1
title_full_unstemmed Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1
title_short Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1
title_sort multimodal imaging findings and treatment with dexamethasone implant in three cases of idiopathic macular telangiectasia type 1
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077428/
https://www.ncbi.nlm.nih.gov/pubmed/33976663
http://dx.doi.org/10.1159/000509850
work_keys_str_mv AT ciraficipaola multimodalimagingfindingsandtreatmentwithdexamethasoneimplantinthreecasesofidiopathicmaculartelangiectasiatype1
AT musolinomaria multimodalimagingfindingsandtreatmentwithdexamethasoneimplantinthreecasesofidiopathicmaculartelangiectasiatype1
AT saccheggianimichela multimodalimagingfindingsandtreatmentwithdexamethasoneimplantinthreecasesofidiopathicmaculartelangiectasiatype1
AT traversocarloenrico multimodalimagingfindingsandtreatmentwithdexamethasoneimplantinthreecasesofidiopathicmaculartelangiectasiatype1
AT nicolomassimo multimodalimagingfindingsandtreatmentwithdexamethasoneimplantinthreecasesofidiopathicmaculartelangiectasiatype1